Zhang and colleagues [24] studied 107 patients with locally advanced ESCC and found that cytokeratin-19 expression and the CEA levels were independent prognostic predictors for ESCC patients treated with concurrent chemoradiotherapy. This evidence concerns the gene CEACAM5 and esophageal squamous cell carcinoma.